Luvo Health's materials describe these ingredients in these terms: B12: supports red blood cell formation and neurological function Methionine: described as a precursor to glutathione Inositol: linked to insulin sensitivity and mood support Choline: described as a precursor to acetylcholine Luvo's content also states that B12 deficiency affects an estimated 15-20% of adults over 60
The literature on both is extensive, and the picture continues to develop
Although compounded drugs are permitted to be prescribed under federal law, they are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review
Pfizer has unsuccessfully attempted to develop two GLP1RA drug candidates, lotiglipron (PF-07081532), co-developed with Heptares Therapeutics Ltd., and danuglipron (PF-06882961), both small molecules and new molecular entities intended for oral delivery for treatment of obesity
"Health effects of cannabis"